Finland· FI-REL-REL18229

Mirtazapin Krka

A mirtazapine product containing mirtazapine, registered in Finland by KRKA d.d. Novo mesto. The same ATC class is registered in 18 of our 19 countries.

ATC N06AX11

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedMirtazapin KrkaATCN06AX11REGISTER NO.FI-REL-REL18229PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Mirtazapine is registered in 18 of 19 countries.

Countries holding a registration under ATC N06AX11 (mirtazapine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 11 of them publish a price we can compare per daily dose

Mirtazapine · ATC N06AX11

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mirtazapine costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.22 in France to $1.40 in Switzerland — a ×6.4 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Mirtazapine · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.40
  • IT Italy$0.61
  • FR France$0.22
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Mirtazapine
Manufacturer
KRKA d.d. Novo mesto
Country
Finland (FI)
ATC code
N06AX11
ATC class
Mirtazapine
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 2

2 priced
  • fi_myyntilupa
    023886
    30
    EUR 8.18
  • fi_myyntilupa
    023897
    100 x 1
    EUR 31.22

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

482 interactions on record for mirtazapine.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Mirtazapine · interactions on record

482 records

  • 50 severe
  • 234 moderate
  • 2 minor
  • 162 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

34 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mirtazapine in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mirtazapine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Mirtabene, Mirtabene Ratiopharm Gmbh
  • Belgium · Mirtazapine Ab, Mirtazapine Eg
  • Bulgaria · Мирзатен, Мирзатен Q-Tab
  • Cyprus · Mirtazapin Aurobindo, Remeron
  • Czechia · Miranox, Mirtazapin +pharma
  • Germany · Mirta, Mirta Tad
  • Denmark · Combar, Mirtazapin "hexal"
  • Estonia · Mirtastad, Mirtazapin Actavis
  • Spain · Afloyan, Mirtazapina Almus
  • France · Mirtazapine Almus, Mirtazapine Arrow
  • United Kingdom (Northern Ireland) · Mirtazapine, Mirtazapine Accord Healthcare
  • Greece · Anchopriv, Azapin
  • Croatia · Calixta, Mirtazapin Genericon
  • Hungary · Mirtadepi, Mirtastad
  • Ireland · Mirap, Mirap Distab
  • Iceland · Míron, Miron Smelt
  • Italy · Mirtazapin Grindeks, Mirtazapina Almus
  • Lithuania · Mirtazapin Actavis, Mirtazapin Grindeks
  • Luxembourg · Mirtazapin Ratiopharm, Mirtazapine Eg
  • Latvia · Mirtastad, Mirtazapine Grindeks
  • Malta · Mirap, Mirap Distab
  • Netherlands · Mirtazapine Amarox, Mirtazapine Aurobindo
  • Norway · Mirtazapin Actavis, Mirtazapin Bluefish
  • Poland · Auromirta Oro, Mirtagen
  • Portugal · Mirtazapin Grindeks, Mirtazapina Almus
  • Romania · Mirtazapin Arena, Mirtazapină Aurobindo
  • Sweden · Mirtazapin Actavis, Mirtazapin Alternova
  • Slovenia · Mirtazapin Grindeks, Mirtazapine Grindeks
  • Slovakia · Mirzaten, Mirzaten Q-Tab

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b83d60b1-e975-41ac-af04-d875716b0b29
GET /v1/drugs/b83d60b1-e975-41ac-af04-d875716b0b29?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "30",
  "form": "tabletti, kalvopäällysteinen",
  "route": "Suun kautta",
  "ddd_unit": "mg",
  "strength": "30 mg",
  "atc_label": "mirtatsapiini",
  "ma_number": "17719",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL18229",
  "authorised_at": "2003-09-26"
}

See everything about mirtazapine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.